Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Diversity and inclusion are critical to business success, particularly when fostering innovation and creativity. At Mednet, ...

Effective brand strategies are like a well-made jigsaw but they can end up looking nothing like the picture that was agreed ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...